Altropane ( DrugBank: Altropane )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05636852 (ClinicalTrials.gov)	March 31, 2023	1/11/2022	Altropane Dose for Imaging Patients With Suspected Parkinson's Disease	An Open-label Multicenter Phase 2 Dose-evaluation Study of Altropane (123I) Injection for Striatal Dopamine Transporter Visualization Using SPECT Brain Imaging	Parkinson Disease;Movement Disorders	Drug: Altropane (123I) Injection	GE Healthcare	Labcorp Drug Development Inc	Not yet recruiting	18 Years	N/A	All	30	Phase 2	NULL
2	NCT00397228 (ClinicalTrials.gov)	November 2006	6/11/2006	ALTROPANE® SPECT Imaging in Patients With Parkinson Disease	Optimizing the Performance of ALTROPANE® SPECT Imaging in Patients With Parkinson Disease	Parkinson Disease	Drug: ALTROPANE®	Molecular NeuroImaging	Institute for Neurodegenerative Disorders	Completed	30 Years	N/A	Both	27	Phase 2	United States